Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
1.57 (1y: -26%)
Market Cap 32.3 M P/E(ttm)
Enterprise Value 58.3 M P/B 0.80
INFU- AMEX (USA)
InfuSystems Holdings, Inc.
Not Rated
Top Ranked Predictable Companies
$1.57
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 0.074
INFU's Cash to Debt is ranked lower than
90% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. INFU: 0.074 )
INFU' s 10-Year Cash to Debt Range
Min: 0.03   Max: 0.38
Current: 0.07
0.03
0.38
Equity to Asset 0.187
INFU's Equity to Asset is ranked lower than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. INFU: 0.187 )
INFU' s 10-Year Equity to Asset Range
Min: -0.18   Max: 0.19
Current: 0.19
-0.18
0.19
Interest Coverage 0.6
INFU's Interest Coverage is ranked lower than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. INFU: 0.6 )
INFU' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 0.6
F-Score: 5
Z-Score: 0.24
M-Score: -2.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) 3.40
INFU's Operating margin (%) is ranked higher than
50% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. INFU: 3.40 )
INFU' s 10-Year Operating margin (%) Range
Min: -121.4   Max: 13.7
Current: 3.4
-121.4
13.7
Net-margin (%) -2.5
INFU's Net-margin (%) is ranked lower than
60% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. INFU: -2.5 )
INFU' s 10-Year Net-margin (%) Range
Min: -83.2   Max: 28.1
Current: -2.5
-83.2
28.1
ROE (%) -3.7
INFU's ROE (%) is ranked lower than
60% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. INFU: -3.7 )
INFU' s 10-Year ROE (%) Range
Min: -113.1   Max: 12.4
Current: -3.7
-113.1
12.4
ROA (%) -1.9
INFU's ROA (%) is ranked lower than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. INFU: -1.9 )
INFU' s 10-Year ROA (%) Range
Min: -59.6   Max: 8.6
Current: -1.9
-59.6
8.6
ROC (Joel Greenblatt) (%) 8.80
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. INFU: 8.80 )
INFU' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -308.8   Max: 41.6
Current: 8.8
-308.8
41.6
Revenue Growth (%) 7.5
INFU's Revenue Growth (%) is ranked lower than
87% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. INFU: 7.5 )
INFU' s 10-Year Revenue Growth (%) Range
Min: 7.5   Max: 60.5
Current: 7.5
7.5
60.5
ยป INFU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with INFU



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/B 0.80
INFU's P/B is ranked higher than
83% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. INFU: 0.80 )
INFU' s 10-Year P/B Range
Min: 0.36   Max: 1.19
Current: 0.8
0.36
1.19
P/S 0.58
INFU's P/S is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. INFU: 0.58 )
INFU' s 10-Year P/S Range
Min: 0.36   Max: 1.67
Current: 0.58
0.36
1.67
PFCF 4.70
INFU's PFCF is ranked higher than
93% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.35 vs. INFU: 4.70 )
INFU' s 10-Year PFCF Range
Min: 2.98   Max: 55.8
Current: 4.7
2.98
55.8
EV-to-EBIT 19.6
INFU's EV-to-EBIT is ranked higher than
53% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.12 vs. INFU: 19.6 )
INFU' s 10-Year EV-to-EBIT Range
Min: 11.3   Max: 34
Current: 19.6
11.3
34

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 6.5
INFU's Price/Net Current Asset Value is ranked lower than
53% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. INFU: 6.5 )
INFU' s 10-Year Price/Net Current Asset Value Range
Min: 6   Max: 29.6
Current: 6.5
6
29.6
Price/Tangible Book 2.4
INFU's Price/Tangible Book is ranked higher than
59% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. INFU: 2.4 )
INFU' s 10-Year Price/Tangible Book Range
Min: 2.2   Max: 2.8
Current: 2.4
2.2
2.8
Price/Median PS Value 0.6
INFU's Price/Median PS Value is ranked higher than
50% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.90 vs. INFU: 0.6 )
INFU' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.2
Current: 0.6
0.5
1.2
Earnings Yield (Greenblatt) 5.10
INFU's Earnings Yield (Greenblatt) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. INFU: 5.10 )
INFU' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 8.8
Current: 5.1
2.9
8.8

Business Description

Infusystem Holdings, Inc. formerly HAPC, INC. was incorporated in Delaware on August 15, 2005 as a blank check Company. The Company completed its initial public offering on April 18, 2006. On September 29, 2006, the Company entered into a Stock Purchase Agreement with I-Flow, Iceland Acquisition Subsidiary and Infusystem. On October 25, 2007, Iceland Acquisition Subsidiary purchased all of the issued and outstanding capital stock of Infusystem from I-Flow and concurrently merged with and into Infusystem. As a result of the merger, Iceland Acquisition Subsidiary ceased to exist as in independent entity and Infusystem, as the Corporation surviving the merger, became its wholly-owned subsidiary. Effective October 25, 2007, the Company changed its corporate name from 'HAPC, INC.' to Infusystem Holdings, Inc. it has one operating segment, which consists solely of Infusystem. The Company is a provider of ambulatory infusion pump management services for oncologists in the United States. Ambulatory infusion pumps are small, lightweight electronic pumps designed to be worn by patients and which allow patients the freedom to move about while receiving chemotherapy treatments. The pumps are battery powered and attached to intravenous administration tubing, which is in turn attached to a reservoir or plastic cassette that contains the chemotherapy drug. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to physicians', offices, infusion clinics and hospital outpatient chemotherapy clinics to be utilized by patients who receive continuous chemotherapy infusions. It provides pump management services for the pumps and associated disposable supply kits to oncology practices in the United States. In addition, it sells safety devices for cytotoxic drug transfer and administration and rents pole-mounted or ambulatory infusion pumps for use within the oncology practice. The Company purchases electronic ambulatory infusion pumps from a variety of suppliers on a non-exclusive basis. Smiths Medical, Inc., Hospira Worldwide, Inc. and WalkMed Infusion, LLC (formerly known as McKinley Medical, LLC) are some of them. The pumps are currently used mainly for continuous infusion of chemotherapy drugs for patients with colorectal cancer. The competition of the Company is mainly composed of regional providers, hospital-owned durable medical equipment ('DME') providers, physician providers and home care infusion providers. Its business is subject to certain regulations.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
ยป More Articles for INFU

Headlines

Articles On GuruFocus.com
Guru of Tomorrow? Young Activist Investor Ryan Morris Dec 21 2012 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial